London-based Valarian, which allows companies to use US cloud providers for AI workloads but retain control of their data, raised a $50M Series A led by NEA
THE SO WHAT
A $50M Series A for Valarian’s “infrastructure sovereignty” play is more evidence that data residency and control are now first-class buying criteria for AI workloads. If you sell into Europe or regulated sectors, expect RFPs to probe exactly how you isolate, govern, and repatriate data on US clouds.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureGold Miners Cadillac, Amapa Minerals Add to Canada IPO Rebound
Gold and minerals names reopening the Canadian IPO window is a reminder that capital is rotating back into hard-asset stories. If you’re an early-stage tech company in Canada, underwrite a more selective public exit path and focus your near-term planning on private capital and strategic buyers instead.
Startups & VentureNew Mountain Capital CEO: AI SaaSpocalypse Is Overstated
When a large private equity shop says the AI-driven SaaS collapse is overstated, the message is that institutional capital still believes in software margins — just with different winners. Founders should read this as a shift in underwriting: durable workflow depth and AI-native expansion paths will get funded, generic horizontal tools will not.
Startups & VentureRussian Billionaire Wins Fight to Boot Manager of Biotech Fund
A $2.5 billion biotech venture fund getting its manager removed in court is a governance story — LPs are asserting harder control when outcomes disappoint. If you manage external capital, expect more aggressive oversight on deployment pace, concentration, and transparency, especially in complex tech verticals.
Startups & VentureArgentina IPO Pipeline Grows as YPF Power Unit Files For US Listing
An Argentine power-generation unit joining a growing US IPO pipeline shows global capital is still hungry for energy and infra exposure. Operators in emerging markets should view US listings as a viable route again — but only if governance and reporting can withstand public-market scrutiny.